Cargando…

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort

Lobular primary breast cancer (PBC) histology has been proposed as a risk factor for contralateral breast cancer (CBC), but results have been inconsistent. We investigated CBC risk and the impact of systemic therapy in lobular versus ductal PBC. Further, CBC characteristics following these histologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akdeniz, Delal, Kramer, Iris, van Deurzen, Carolien H. M., Heemskerk‐Gerritsen, Bernadette A. M., Schaapveld, Michael, Westenend, Pieter J., Voogd, Adri C., Jager, Agnes, Steyerberg, Ewout W., Sleijfer, Stefan, Schmidt, Marjanka K., Hooning, Maartje J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939202/ https://www.ncbi.nlm.nih.gov/pubmed/36127572 http://dx.doi.org/10.1002/cam4.5235

Ejemplares similares

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study
por: Akdeniz, Delal, et al.
Publicado: (2021)

Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age
por: Drooger, Jan C., et al.
Publicado: (2015)

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
por: Giardiello, Daniele, et al.
Publicado: (2020)

Corrigendum to “The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer” [Breast 52 (2020) 102–109]
por: van Barele, Mark, et al.
Publicado: (2020)

The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer
por: van Barele, Mark, et al.
Publicado: (2020)

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer
por: Kaas, R, et al.
Publicado: (2003)

Prediction and clinical utility of a contralateral breast cancer risk model
por: Giardiello, Daniele, et al.
Publicado: (2019)

Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation
por: van Barele, Mark, et al.
Publicado: (2023)

Patterns of metastasis in women with metachronous contralateral breast cancer
por: Vichapat, V, et al.
Publicado: (2012)

Prediction of outcome after diagnosis of metachronous contralateral breast cancer
por: Alkner, Sara, et al.
Publicado: (2011)

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
por: van Barele, Mark, et al.
Publicado: (2021)

Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
por: Lobbes, Marc B.I., et al.
Publicado: (2017)

Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
por: Schaapveld, M, et al.
Publicado: (2012)

Breast implant-associated anaplastic large cell lymphoma with contralateral invasive lobular carcinoma
por: Johnson, Lisa, et al.
Publicado: (2020)

Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2018)

The effect of attendance in the Dutch breast cancer screening program on breast tumor characteristics among migrant women
por: Dassen, R.R.E., et al.
Publicado: (2023)

Correction to: Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2018)

Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: a systematic review
por: Robertson, Clare, et al.
Publicado: (2011)

Contrast-enhanced MRI in evaluating the contralateral breast for synchronous malignancy in patients with invasive lobular cancer
por: Pietrosanu, R, et al.
Publicado: (2012)

Metachronous Contralateral Breast Cancer in Ahmadu Bello University Teaching Hospital, Zaria, Northwestern Nigeria
por: Abur, Peter Pase, et al.
Publicado: (2022)

PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients
por: Giardiello, Daniele, et al.
Publicado: (2022)

Traumatic Metachronous Penile Fracture to the Contralateral Corpora
por: Papaioannou, Christos, et al.
Publicado: (2022)

Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients
por: Giardiello, Daniele, et al.
Publicado: (2022)

Is pretreatment assessment of the contralateral breast with MRI useful following a new diagnosis of invasive lobular cancer?
por: Russell, Harriet, et al.
Publicado: (2015)

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers
por: Obdeijn, Inge-Marie, et al.
Publicado: (2020)

Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database
por: Qiu, Ruiyue, et al.
Publicado: (2019)

Prior Adjuvant Tamoxifen Treatment in Breast Cancer Is Linked to Increased AIB1 and HER2 Expression in Metachronous Contralateral Breast Cancer
por: Alkner, Sara, et al.
Publicado: (2016)

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
por: Schaapveld, Michael, et al.
Publicado: (2007)

Invasive lobular carcinoma of the breast.
por: Hayes, D., et al.
Publicado: (1981)

Metachronous Contralateral Axillary Lymph Node Metastasis from Invasive Breast Carcinoma: A Case Report with Imaging Findings
Publicado: (2022)

Survival and contralateral breast cancer in CHEK2 1100delC breast cancer patients: impact of adjuvant chemotherapy
por: Kriege, M, et al.
Publicado: (2014)

HER2-low breast cancer shows a lower immune response compared to HER2-negative cases
por: van den Ende, Nadine S., et al.
Publicado: (2022)

MRI evaluation of multifocality and contralateral disease in lobular breast cancer: what can we learn from one region's experience?
por: Magee, Claire, et al.
Publicado: (2015)

Stromal Changes are Associated with High P4HA2 Expression in Ductal Carcinoma in Situ of the Breast
por: Agahozo, Marie Colombe, et al.
Publicado: (2022)

The spectrum of ATM missense variants and their contribution to contralateral breast cancer
por: Broeks, Annegien, et al.
Publicado: (2007)

Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis
por: van Maaren, Marissa C., et al.
Publicado: (2021)

Expression of high-affinity 67-kDa laminin receptors in primary breast cancers and metachronous metastatic lesions or contralateral cancers.
por: Daidone, M. G., et al.
Publicado: (1997)

Comparison of the Imaging Features of Lobular Carcinoma In Situ and Invasive Lobular Carcinoma of the Breast
Publicado: (2021)

MRI characteristics of lobular carcinoma of the breast
por: Leaver, A, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lcfs6dd6imt14gnei5snet24ih